Explore the vast range of titles available.

Background The aim of this study is to investigate whether planned caesarean delivery compared to planned induction of labour in women with severe pre-eclampsia at gestational age of more than 37 weeks of pregnancy will reduce maternal morbidity and/or perinatal morbidity. Method This randomized controlled study was conducted from April 2021 to March 2022 at Department of Obstetrics and Gynecology of Midnapore Medical College, West Bengal. Data were analysed with respect to socio demographic status, clinical presentation, complications and their management. Result One hundred and seventy-six women with severe pre-eclampsia were screened for eligibility, and 140 were included in the study. In 58.6% patients, the induction was successful. Type of delivery was successful in vaginal 37 (90.2%) and instrumental (ventouse and forceps) in four (19.8%) of the cases. In induction group, the most common reason for LSCS was MSL with foetal bradycardia. Foetal distress was seen in 22.90% of induction group, while absent in LSCS group. Conclusion In our study, we found that there was no differences in the primary maternal outcome and the secondary maternal outcome between the two groups. The primary neonatal outcome was significantly poor in induction group, whereas good in LSCS group. So LSCS is better option in patients with severe pre-eclampsia at term. Key words—Severe Pre-eclampsia, Induction of labour.

The aim of the study was to estimate the prevalence of maternal near miss (MNM) and maternal death and to identify the factors associated with severe maternal outcome in women with eclampsia according to the World Health Organization (WHO) maternal near-miss criteria. A cross-sectional study was carried out over a period of 12 months incorporating pregnant women diagnosed as eclampsia during antepartum and postpartum period. The definition of maternal near miss was applied according to the WHO near-miss criteria. Data were collected in a case record form specially designed for the study and analyzed using statistical software. A total of 229 women with eclampsia included in the study over a period of 1 year. Among 229 women with eclampsia, 75 (32.75%) women diagnosed as maternal near miss (MNM), and 6 (2.62%) women had maternal death. Causes of near miss were neurological dysfunction (30.66%), respiratory dysfunction (24%), hematological dysfunction (18.67%), cardiological dysfunction (16%), hepatic dysfunction (10.67%) and uterine dysfunction (5.33%). Maternal near-miss ratio is 4.91 per 1000 live births, and severe maternal outcome ratio is 5.30 per 1000 live birth. Maternal near-miss mortality ratio (MNM:1MD) is 12.5:1, and mortality index is 7.40. The study shows that there is scope to improve antenatal care and utilization of health facilities. Early diagnosis, good perinatal supervision and appropriate treatment can ameliorate many cases.

Objective The aim of the study was to estimate the prevalence of maternal near miss (MNM) and maternal death and to identify the factors associated with severe maternal outcome in women with eclampsia according to the World Health Organization (WHO) maternal near-miss criteria. Method A cross-sectional study was carried out over a period of 12 months incorporating pregnant women diagnosed as eclampsia during antepartum and postpartum period. The definition of maternal near miss was applied according to the WHO near-miss criteria. Data were collected in a case record form specially designed for the study and analyzed using statistical software. Result A total of 229 women with eclampsia included in the study over a period of 1 year. Among 229 women with eclampsia, 75 (32.75%) women diagnosed as maternal near miss (MNM), and 6 (2.62%) women had maternal death. Causes of near miss were neurological dysfunction (30.66%), respiratory dysfunction (24%), hematological dysfunction (18.67%), cardiological dysfunction (16%), hepatic dysfunction (10.67%) and uterine dysfunction (5.33%). Maternal near-miss ratio is 4.91 per 1000 live births, and severe maternal outcome ratio is 5.30 per 1000 live birth. Maternal near-miss mortality ratio (MNM:1MD) is 12.5:1, and mortality index is 7.40. Conclusion The study shows that there is scope to improve antenatal care and utilization of health facilities. Early diagnosis, good perinatal supervision and appropriate treatment can ameliorate many cases.

The aim of this study is to investigate whether planned caesarean delivery compared to planned induction of labour in women with severe pre-eclampsia at gestational age of more than 37 weeks of pregnancy will reduce maternal morbidity and/or perinatal morbidity. This randomized controlled study was conducted from April 2021 to March 2022 at Department of Obstetrics and Gynecology of Midnapore Medical College, West Bengal. Data were analysed with respect to socio demographic status, clinical presentation, complications and their management. One hundred and seventy-six women with severe pre-eclampsia were screened for eligibility, and 140 were included in the study. In 58.6% patients, the induction was successful. Type of delivery was successful in vaginal 37 (90.2%) and instrumental (ventouse and forceps) in four (19.8%) of the cases. In induction group, the most common reason for LSCS was MSL with foetal bradycardia. Foetal distress was seen in 22.90% of induction group, while absent in LSCS group. In our study, we found that there was no differences in the primary maternal outcome and the secondary maternal outcome between the two groups. The primary neonatal outcome was significantly poor in induction group, whereas good in LSCS group. So LSCS is better option in patients with severe pre-eclampsia at term. Key words-Severe Pre-eclampsia, Induction of labour.